4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000067
Chief Financial Officer sold 11,063 shares at $12.99 ($143,708)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barnett Eva Renee Chief Financial Officer | 2025-04-09 | Sale | −7,013 | $12.99 | $91,099 | 403,817 | D |
| Barnett Eva Renee Chief Financial Officer | 2025-04-09 | Sale | −4,050 | $12.99 | $52,610 | 399,767 | D |
| Open-market sales · 11,063 sh · avg $12.99 · $143,708 | |||||||
Loading xslF345X05/wk-form4_1744401967.xml…